Explore our product offering by market:
We are a world leader in pharmaceutical excipients, vaccine adjuvants and lipid delivery systems for human and veterinary applications.
Human pharmaceuticals
We specialise in developing the highest quality and purest grades of pharmaceutical excipients, lipids and vaccine adjuvants to help you formulate seamlessly and drive your products to market. We tailor excipient purity to your needs. We are committed to product quality, regulatory excellence, and supply chain security. We have worked with many pharma companies to bring COVID-19 vaccines and treatments to market faster, using our adjuvant and Super Refined™ excipients. While continuing to invest in expanding our portfolio and manufacturing footprint globally, quality is at the forefront of our plans.
Veterinary health
To serve the growing veterinary health market, we develop and commercialise a wide range of specialty excipients which are used to enhance the delivery, efficacy, and stability of actives in livestock and companion animal health products. Our broad portfolio also comprises adjuvants for the important veterinary vaccine market and extends further to omega-3 essential fatty acids for pet food products. We collaborate with your formulation scientists to produce safer, more efficient, and highly specialised products that are used across a variety of marketed veterinary dosage forms. We strive to offer innovative solutions to meet the challenges formulators, veterinarians and livestock producers face every day.
Explore recent blogs:
Insights into the veterinary health market
The veterinary market in the EMEA region is expected to experience substantial growth in the coming years: 5-8% CAGR. Typically, the veterinary market is categorised into companion animals and...
World Cancer Day 2025
In 2022 alone, 9.7 million people worldwide lost their lives to cancer, and the number of new cases is expected to rise to nearly 30 million by 2040. It is a disease that takes so much from so many,...
New Research Professor MSO in Vaccine Adjuvants at Statens Serum Institut Copenhagen, Denmark
PRESS RELEASE: Croda Pharma is happy to announce that Dennis Christensen, PhD, Head of Global Research and Development for Vaccine Adjuvant Systems, has been appointed as a part-time Research...